These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Development of the endocrine function of the kidney. Bailie MD Clin Perinatol; 1992 Mar; 19(1):59-68. PubMed ID: 1576774 [TBL] [Abstract][Full Text] [Related]
83. The Bothrops legacy: vasoactive peptides from Brazil. Luft FC J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):57-64. PubMed ID: 18404610 [No Abstract] [Full Text] [Related]
84. A structural network associated with the kallikrein-kinin and renin-angiotensin systems. Stoka V; Turk V Biol Chem; 2010 Apr; 391(4):443-54. PubMed ID: 20180650 [TBL] [Abstract][Full Text] [Related]
86. [Neurohormonal mechanisms in congestive heart failure]. Goch JH Pol Arch Med Wewn; 1992; 88(2-3):171-4. PubMed ID: 1492022 [No Abstract] [Full Text] [Related]
87. Local renin-angiotensin system and the brain--a continuous quest for knowledge. Baltatu OC; Campos LA; Bader M Peptides; 2011 May; 32(5):1083-6. PubMed ID: 21333703 [TBL] [Abstract][Full Text] [Related]
88. Atrial natriuretic factor: a new hormone with possible clinical importance. Zeigler DW; Zawada ET; Kauker ML S D J Med; 1987 Mar; 40(3):21-4. PubMed ID: 2951848 [No Abstract] [Full Text] [Related]
89. [Current data on the extrarenal renin-angiotensin system]. Haulică I; Petrescu G; Slătineanu S; Bild W Rev Med Chir Soc Med Nat Iasi; 1999; 103(3-4):25-34. PubMed ID: 10756922 [TBL] [Abstract][Full Text] [Related]
90. [The role of the renin-angiotensin and kallikrein-kinin systems and of a number of hormonal substances in the pathogenesis of the acute period in myocardial infarct]. Dobrin BIu; Kuskov SV Lik Sprava; 1997; (6):14-7. PubMed ID: 9589915 [No Abstract] [Full Text] [Related]
91. Vasoactive factors in the immature kidney. Guignard JP; Gouyon JB; John EG Pediatr Nephrol; 1991 Jul; 5(4):443-6. PubMed ID: 1832925 [TBL] [Abstract][Full Text] [Related]
92. Peptidergic control of cardiovascular function: the angiotensin paradigm. Ganten D Eur Heart J; 1990 Apr; 11 Suppl B():72-8. PubMed ID: 2194811 [TBL] [Abstract][Full Text] [Related]
93. The renin-angiotensin system: it's all in your head. Parsons KK; Coffman TM J Clin Invest; 2007 Apr; 117(4):873-6. PubMed ID: 17404616 [TBL] [Abstract][Full Text] [Related]
94. The tissue renin-angiotensin systems in cardiovascular disease. Paul M; Bachmann J; Ganten D Trends Cardiovasc Med; 1992; 2(3):94-9. PubMed ID: 21239267 [TBL] [Abstract][Full Text] [Related]
96. Mechanisms for escape from the salt-retaining effects of mineralocorticoids: role of deep nephrons. Haas JA; Knox FG Semin Nephrol; 1990 Jul; 10(4):380-7. PubMed ID: 2143307 [No Abstract] [Full Text] [Related]
97. [Endocrine function of the cardiovascular system]. Horký K Cas Lek Cesk; 1993 Feb; 132(2):33-7. PubMed ID: 8453647 [TBL] [Abstract][Full Text] [Related]
98. The role of atrial natriuretic peptide in cardiac surgery. Miller ED J Cardiothorac Anesth; 1988 Jun; 2(3):271-3. PubMed ID: 17171859 [No Abstract] [Full Text] [Related]
99. Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system. Lavoie JL; Sigmund CD Endocrinology; 2003 Jun; 144(6):2179-83. PubMed ID: 12746271 [TBL] [Abstract][Full Text] [Related]
100. Transgenic animal models for the functional analysis of vasoactive peptides. Bader M Braz J Med Biol Res; 1998 Sep; 31(9):1171-83. PubMed ID: 9876285 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]